Development and validation of convective‐diffusion models to analyse the transient behaviour of a packed bed: Factors influencing aqueous phase adsorption of a bisbiguanide

Chlorhexidine gluconate [CHG] in combination with cetrimide [CET], widely used in various pharmaceutical compositions, is potentially hazardous to aquatic ecosystems. Continuous removal of these compounds using commercial [GAC] and functionalized activated carbons [FACs] in a packed bed column, is reported. Transient forms of convective diffusion models are developed with depletion terms being represented by the first and second-order kinetics. Performance of the packed bed is analysed with varying bed height, flow rate, initial concentrations, and estimated Damköhler numbers. On the basis of minimum value of sum of the squares of residuals [SSQ], it is evident that the second-order model fits better for the removal of CHG and CET by FACHF and FACNH3, while the first-order model fits better for GAC. Damköhler number increases with a decrease in flow rate for both the compounds. Ratio of Damköhler numbers does not change with flow rate. Irrespective of flow rates, for GAC: Da2(CHG):Da2(CET) ≈ 0.0526;for FACHF: Da2(CHG):Da2(CET)=0.30;for FACNH3: Da2(CHG):Da2(CET) = 0.0076. Changes in the breakthrough volume (nBT,max), causing the analytes to migrate from the front of the adsorbent bed into the back, are in the order: for CHG: nBT,max(FACHF) >nBT,max (FACNH3) >nBT,max (GAC);for CET: nBT,max (FAC- NH3) >nBT,max (FACHF) >nBT,max (GAC).

Efficacy of convective-diffusion models to study the transient behaviour of a sewage-sludge-filled packed column for aqueous phase adsorption of fluoroquinolones: Consideration of pseudo-kinetics driven depletion of species

Ciprofloxacin and ofloxacin belong to a class of antibiotics called Fluoroquinolones (FQs), which have a wide anti-bacterial activity against Gram-positive and Gram-negative bacteria. Since the recent Covid-19 pandemic witnessed a magnanimous rise in the use of antibiotics to prevent secondary bacterial infections, it led to vast production and use of such antibiotics. Ultimately the antibiotics get discharged into the municipal sewer pipes, thereby killing the useful microbial colony. In order to prevent environmental degradation a commercial scale-up of the adsorption of these antibiotics using raw sewage sludge is an absolute necessity. In this study, a continuous adsorption operation is conducted in a packed bed of semi-dried raw sewage sludge to remove the FQs from wastewater. Two transient convective-diffusion models are developed including pseudo-first and second-order kinetics driven depletion terms. The models are optimised using the data collected under various dynamic conditions in order to analyse the performance of the packed bed in terms of bed height, flow rate and initial concentration of the FQs. Damköhler numbers of the FQs are estimated to predict the breakthrough times of both the FQs. The ratios of Damköhler numbers of ciprofloxacin and ofloxacin do not change much with flow rate. In all the experiments, Das << 1 for both the FQs, indicating a faster diffusion process with respect to the rate of pseudo-reaction. Diffusion reaches an ‘equilibrium' well before the reaction achieves pseudo-chemical equilibrium. Ratios of the Damköhler numbers, meant to represent the first-order and second-order convective-diffusion models for ciprofloxacin to ofloxacin is < 1. © 2023 Elsevier Ltd

High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.

Hepatitis C virus (HCV) infections pose a major public health burden due to high chronicity rates and associated morbidity and mortality. A vaccine protecting against chronic infection is not available but would be important for global control of HCV infections. In this study, cell culture-based HCV production was established in a packed-bed bioreactor (CelCradle™) aiming to further the development of an inactivated whole virus vaccine and to facilitate virological and immunological studies requiring large quantities of virus particles. HCV was produced in human hepatoma-derived Huh7.5 cells maintained in serum-free medium on days of virus harvesting. Highest virus yields were obtained when the culture was maintained with two medium exchanges per day. However, increasing the total number of cells in the culture vessel negatively impacted infectivity titers. Peak infectivity titers of up to 7.2 log10 focus forming units (FFU)/mL, accumulated virus yields of up to 5.9 × 1010 FFU, and a cell specific virus yield of up to 41 FFU/cell were obtained from one CelCradle™. CelCradle™-derived and T flask-derived virus had similar characteristics regarding neutralization sensitivity and buoyant density. This packed-bed tide-motion system is available with larger vessels and may thus be a promising platform for large-scale HCV production.

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production in the scalable packed-bed CelCradleTM 500-AP bioreactor. CelCradleTM 500-AP bottles with 0.5 L working volume and 5.5 g BioNOC™ II carriers were seeded with 1.5 × 108 Vero (WHO) cells, approved for vaccine production, in animal component-free medium and infected at a multiplicity of infection of 0.006 at a total cell number of 2.2-2.5 × 109 cells/bottle seven days post cell seeding. Among several tested conditions, two harvests per day and a virus production temperature of 33 °C resulted in the highest virus yield with a peak SARS-CoV-2 infectivity titer of 7.3 log10 50% tissue culture infectious dose (TCID50)/mL at 72 h post-infection. Six harvests had titers of ≥6.5 log10 TCID50/mL, and a total of 10.5 log10 TCID50 were produced in ~5 L. While trypsin was reported to enhance virus spread in cell culture, addition of 0.5% recombinant trypsin after infection did not improve virus yields. Overall, we demonstrated successful animal component-free production of SARS-CoV-2 in well-characterized Vero (WHO) cells in a scalable packed-bed bioreactor.

Design and performance evaluation of a photocatalytic reactor for indoor air disinfection.

Since COVID-19 pandemic, indoor air quality control has become a priority, and the development of air purification devices effective for disinfecting airborne viruses and bacteria is of outmost relevance. In this work, a photocatalytic device for the removal of airborne microorganisms is presented. It is an annular reactor filled with TiO2-coated glass rings and irradiated internally and externally by UV-A lamps. B. subtilis spores and vegetative cells have been employed as model biological pollutants. Three types of assays with aerosolized bacterial suspensions were performed to evaluate distinct purification processes: filtration, photocatalytic inactivation in the air phase, and photocatalytic inactivation over the TiO2-coated rings. The radiation distribution inside the reactor was analysed by performing Monte Carlo simulations of photon absorption in the photocatalytic bed. Complete removal of a high load of microorganisms in the air stream could be achieved in 1 h. Nevertheless, inactivation of retained bacteria in the reactor bed required longer irradiation periods: after 8 h under internal and external irradiation, the initial concentration of retained spores and vegetative cells was reduced by 68% and 99%, respectively. Efficiency parameters were also calculated to evaluate the influence of the irradiation conditions on the photocatalytic inactivation of bacteria attached at the coated rings.

Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond.

This work describes the design and implementation of an automated device for catalytic materials testing by direct modifications to a gas chromatograph (GC). The setup can be operated as a plug-flow isothermal reactor and enables the control of relevant parameters such as reaction temperature and reactant partial pressures directly from the GC. High-quality kinetic data (including reaction rates, product distributions, and activation barriers) can be obtained at almost one-tenth of the fabrication cost of analogous commercial setups. With these key benefits including automation, low cost, and limited experimental equipment instrumentation, this implementation is intended as a high-throughput catalyst screening reactor that can be readily utilized by materials synthesis researchers to assess the catalytic properties of their synthesized structures in vapor-phase chemistries.